<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00435058</url>
  </required_header>
  <id_info>
    <org_study_id>CEP 1021/05</org_study_id>
    <nct_id>NCT00435058</nct_id>
  </id_info>
  <brief_title>Visual Function Changes After Intraocular Pressure Reduction</brief_title>
  <official_title>Visual Function Changes After Intraocular Pressure Reduction Using Antiglaucoma Medications: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <brief_summary>
    <textblock>
      During the glaucomatous disease process, subpopulations of cells may be dead, damaged or
      healthy. Visual function changes could be observed due to a recovering of the suffering
      ganglion cells after the intraocular pressure reduction. This study aims at evaluating the
      correlation between intraocular pressure reduction and visual function changes in glaucoma
      patients after using antiglaucoma medications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary open angle glaucoma patients without use of antiglaucoma medications will be enrolled
      in this study. After inclusion, the patients will randomly receive one of three antiglaucoma
      medications (timolol maleate 0,5%, brimonidine tartrate 0,2% or travoprost 0,004%) in one
      randomly selected eye.

      The patients will be evaluated with Goldmann applanation tonometry, visual acuity test,
      contrast sensitivity test, visual quality perception test (visual analogue scale) and
      standard automated perimetry before and after 4 weeks of glaucoma treatment onset.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date>April 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraocular pressure</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>contrast sensitivity</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>visual quality perception</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean deviation of the visual field (MD)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pattern Standard Deviation of the visual field (PSD)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual acuity</measure>
  </secondary_outcome>
  <enrollment>54</enrollment>
  <condition>Glaucoma</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>timolol maleate 0,5%</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>brimonidine tartrate 0,2%</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>travoprost 0,004%</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary open angle glaucoma

          -  Intraocular pressure greater than 21 mmHg

        Exclusion Criteria:

          -  Best corrected visual acuity (BCVA) worse than 20/80

          -  Significant media opacity

          -  History of steroid use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tiago Prata, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luiz A Melo Jr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2007</study_first_submitted>
  <study_first_submitted_qc>February 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 14, 2007</study_first_posted>
  <last_update_submitted>February 16, 2007</last_update_submitted>
  <last_update_submitted_qc>February 16, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2007</last_update_posted>
  <keyword>intraocular pressure</keyword>
  <keyword>contrast sensitivity</keyword>
  <keyword>visual function</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Timolol</mesh_term>
    <mesh_term>Brimonidine Tartrate</mesh_term>
    <mesh_term>Travoprost</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

